How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
New pathway found connecting liver congestion to fibrosis and cancer
Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through…
Researchers develop new score to predict the risk of liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed…
Study explores whether a bidirectional causal link exists between MASLD and sarcopenia
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) and sarcopenia frequently coexist, yet their causal relationship and…
High-fat diets cause more damage to metabolic health than carbohydrates
In recent years, many media reports and social media influencers have emphasized the dangers of eating too many…
Normal BMI hides nutritional gaps in alcohol use disorder
A sweeping review shows that while calorie intake and BMI often appear normal in people with alcohol use…
Dynamic viral markers predict treatment response in hepatitis B
Background and aims The rate of functional cure (HBsAg loss) remains unsatisfactory following pegylated interferon (PEG-IFN) treatment in…
ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research
Microbiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept…
Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy
Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps…
Bacterial infections in patients with liver cirrhosis show rising prevalence and high mortality
Background and aims Bacterial infections (BIs) are common and severe complications in patients with liver cirrhosis, but global…
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
Chemotherapy-induced gut changes trigger anti-metastatic immune response
Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to…